Suvretta Capital Management, LLC Bolt Biotherapeutics, Inc. Transaction History

Suvretta Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.48 - $2.61 $653,790 - $1.15 Million	441,750 Added 19.81%	2,672,000 $3.96 Million
Q4 2021 Feb 14, 2022	BUY	$4.19 - $13.97 $3.79 Million - $12.6 Million	904,750 Added 68.26%	2,230,250 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$11.15 - $18.6 $4.14 Million - $6.91 Million	371,411 Added 38.93%	1,325,500 $16.8 Million
Q2 2021 Aug 16, 2021	BUY	$15.4 - $31.46 $8.22 Million - $16.8 Million	533,724 Added 126.97%	954,089 $14.8 Million
Q1 2021 May 17, 2021	BUY	$25.86 - $39.93 $10.9 Million - $16.8 Million	420,365 New	420,365 $13.8 Million

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.